DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-19075 | Pharmaceuticals
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Dendritic Cell Cancer Vaccine Industry Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET
7.1 GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA DENDRITIC CELL CANCER VACCINE INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Glaxo Smith Kline
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Bellicum Pharmaceuticals
16.3 Elios Therapeutics
16.4 DCPrime
16.5 Creagene
16.6 3M Company
16.7 SOTIO
16.8 Batavia Bioservices
16.9 Merck
16.10 ImmunoCellular Therapeutics
16.11 Northwest Biotherapeutics
16.12 ImmunoCellular Therapeutics
16.13 DanDrit Biotech
16.14 Argos Therapeutics
16.15 Theravectys
16.16 Tella Incorporation
16.17 Activartis
16.18 Medigene
16.19 Immunicum
16.20 Kiromic
16.21 Vaxil BioTherapeutics
16.22 Dendreon Corporation
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :CreaVax
Tumor Antigen Presenting Cells
Provenge
Market by Application :
Medical Research
Cancer Hospital
Others
Companies
Glaxo Smith Kline
Bellicum Pharmaceuticals
Elios Therapeutics
DCPrime
Creagene
3M Company
SOTIO
Batavia Bioservices
Merck
ImmunoCellular Therapeutics
Northwest Biotherapeutics
ImmunoCellular Therapeutics
DanDrit Biotech
Argos Therapeutics
Theravectys
Tella Incorporation
Activartis
Medigene
Immunicum
Kiromic
Vaxil BioTherapeutics
Dendreon Corporation
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.